Back
SPDR® S&P Pharmaceuticals ETF Vs. Dave Industry Stock Comparison
Buy
67
XPH
SPDR® S&P Pharmaceuticals ETF
Last Price:
46.28
Seasonality Move:
4.28%
Buy
99
DAVE
Dave
Last Price:
79.94
Seasonality Move:
82.07%
Buy
67
SPDR® S&P Pharmaceuticals ETF (XPH)
is a Buy
Is SPDR® S&P Pharmaceuticals ETF a Buy, Sell or Hold?
- The current SPDR® S&P Pharmaceuticals ETF [XPH] share price is $47.16. The Score for XPH is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- XPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
99
Dave (DAVE)
is a Buy
Is Dave a Buy, Sell or Hold?
- The current Dave [DAVE] share price is $90.46. The Score for DAVE is 99, which is 98% above its historic median score of 50, and infers lower risk than normal.
- DAVE is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
XPH Stock Price Chart
What is SPDR® S&P Pharmaceuticals ETF's stock price today?
-
The SPDR® S&P Pharmaceuticals ETF share price today is $47.16
The current trend is moderately bearish and XPH is experiencing selling pressure, which indicates risk of future bearish movement.
XPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.65 | Buy |
Relative Strength Index (14 RSI): | 57.37 | Buy |
Chaikin Money Flow: | -9446 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
DAVE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.7 | Buy |
Relative Strength Index (14 RSI): | 89.82 | Buy |
Chaikin Money Flow: | 1682432 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.65 - 56.79) | Buy |
Bollinger Bands (100): | (31.2 - 46.26) | Buy |
XPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.25 | Sell |
20-day SMA: | 46.75 | Buy |
50-day SMA: | 45.28 | Buy |
200-day SMA: | 42.75 | Buy |
8-day EMA: | 47.28 | Sell |
20-day EMA: | 46.68 | Buy |
50-day EMA: | 45.53 | Buy |
200-day EMA: | 43.11 | Buy |
DAVE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.07 | Buy |
20-day SMA: | 46.26 | Buy |
50-day SMA: | 42.24 | Buy |
200-day SMA: | 37.25 | Buy |
8-day EMA: | 59.69 | Buy |
20-day EMA: | 49.96 | Buy |
50-day EMA: | 44.12 | Buy |
200-day EMA: | 35.62 | Buy |
SPDR® S&P Pharmaceuticals ETF Earnings Growth & XPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Dave Earnings Growth & DAVE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.43 per share.
SPDR® S&P Pharmaceuticals ETF Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dave Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |